EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human antibody targeting of coronavirus spike S2 subunit is associated with protection mediated by Fc effector functions

Krithika Muthuraman iD, Matthew Jackman, Yu Liang, Meghan E Garrett, Hong Cui, Loan Vu Hong Nguyen, Danton Ivanochko, Chengjin Ye iD, Paula A Pino, Amberlee Hicks, Billie Maingot, Erik Yusko und 8 weitere

Journal of Virology · 2025

DOI: 10.1128/jvi.01523-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2025. Verfasst von Krithika Muthuraman und 19 weiteren Autor:innen. Beteiligte Einrichtung: Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Antibodies, Viral, SARS-CoV-2, Antibodies, Neutralizing. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Gates Foundation, Bill and Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past two decades, betacoronaviruses (β-CoVs) have caused two epidemics and a pandemic and remain a high risk for future outbreaks through zoonotic transmissions, highlighting the need for broad biomedical countermeasures. Here, we describe a convalescent human monoclonal antibody (mAb 1871) that targets the S2 subunit of the coronavirus spike protein, with broad β-CoVs binding and sarbecovirus neutralization. Cryo-electron microscopy analysis revealed that mAb 1871 binds the upstream helix of the S2 subunit, interacting with partially conserved residues, providing a molecular basis for its cross-reactivity. Though less potent than receptor-binding domain-directed antibodies—approximately 500-fold lower neutralization potency than the emergency use authorized receptor-binding domain (RBD)-directed Pemgarda mAb against wild-type SARS-CoV-2—mAb 1871 provides protective efficacy in a mouse model. Notably, Fc effector functions are critical for its in vivo protection. This study further highlights the Fc dependence of S2-directed antibodies for in vivo protection and identifies a conserved epitope in the S2 subunit as a potential target of broad-β-CoVs countermeasures. IMPORTANCE Bats and pangolins are natural reservoirs of betacoronaviruses (β-CoVs) and continue to pose a significant risk for future outbreaks through zoonotic transmissions. This highlights the need for effective countermeasures to prevent future pandemics. While neutralizing antibodies targeting the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) received emergency use authorization, many have lost efficacy as the virus evolved, and authorizations have been revoked. In contrast to the S1 subunit, the spike protein S2 subunit is more conserved across β-CoVs, making it an attractive target for the development of broadly neutralizing antibodies. Here, we describe a human mAb that targets a conserved epitope in the S2 subunit, demonstrating broad β-CoV binding, sarbecovirus neutralization, and in vivo protection mediated by Fc effector functions in a mouse model. These findings have important implications for pan-β-CoVs therapeutics and vaccine development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusAntibodies, ViralSARS-CoV-2Antibodies, NeutralizingAntibodies, MonoclonalCOVID-19Immunoglobulin Fc FragmentsAnimalsHumansMiceCryoelectron MicroscopyCross ReactionsFemaleMice, Inbred BALB C

Stichwörter der Autor:innen

S2 subunitantibodycoronavirus spikecryo-EM structurein vivo protection

Substanzen

Spike Glycoprotein, CoronavirusAntibodies, ViralAntibodies, NeutralizingAntibodies, Monoclonalspike protein, SARS-CoV-2Immunoglobulin Fc Fragments

Autor:innen und Institutionen

  • Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, Ontario, Canada.
  • Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
  • Adaptive Biotechnologies, Seattle, Washington, USA.
  • Population Health Program, Texas Biomedical Research Institute, San Antonio, Texas, USA.
  • International Center for Advancement of Research & Education (I· CARE), San Antonio, Texas, USA.
  • Department of Immunology, University of Toronto, Toronto, Ontario, Canada.

ORCID-Profile: Krithika Muthuraman, Chengjin Ye, Luis Martínez-Sobrido, Jean-Philippe Julien

Förderung

  • NIH HHS
  • Gates Foundation
  • Bill and Melinda Gates Foundation

Zitieren

APA

Muthuraman, K., Jackman, M., Liang, Y., Garrett, M. E., Cui, H., Nguyen, L. V. H., Ivanochko, D., Ye, C., Pino, P. A., Hicks, A., Maingot, B., Yusko, E., Benzeno, S., Martínez-Sobrido, L., Torrelles, J. B., Gilbert, A. E., Rubin, B. E. R., Keitany, G., Jetha, A., & Julien, J. P. (2025). Human antibody targeting of coronavirus spike S2 subunit is associated with protection mediated by Fc effector functions. Journal of Virology. https://doi.org/10.1128/jvi.01523-25

Vancouver

Muthuraman K, Jackman M, Liang Y, Garrett ME, Cui H, Nguyen LVH, et al. Human antibody targeting of coronavirus spike S2 subunit is associated with protection mediated by Fc effector functions. Journal of Virology. 2025. doi:10.1128/jvi.01523-25

BibTeX
@article{Muthuraman2025,
  author = {Muthuraman, Krithika and Jackman, Matthew and Liang, Yu and Garrett, Meghan E and Cui, Hong and Nguyen, Loan Vu Hong and Ivanochko, Danton and Ye, Chengjin and Pino, Paula A and Hicks, Amberlee and Maingot, Billie and Yusko, Erik and Benzeno, Sharon and Martínez-Sobrido, Luis and Torrelles, Jordi B and Gilbert, Amy E and Rubin, Benjamin Evan Russell and Keitany, Gladys and Jetha, Arif and Julien, Jean-Philippe},
  title = {Human antibody targeting of coronavirus spike S2 subunit is associated with protection mediated by Fc effector functions},
  journal = {Journal of Virology},
  year = {2025},
  doi = {10.1128/jvi.01523-25}
}
Kostenlos starten →